Background: Hemangiomas are vascular tumors, i.e. neoplasms of the vascular network. These are the most common neoplasms in the age of infancy. They can be infantile and congenital. Objective: Present the case of a 7.5-year-old girl suffering from a benign vascular tumor–hemangiomatosis of the skin and liver, which is part of the autosomal recessive syndrome SDC (Spondylocostal dysostosis). Case presentation: This case shows that hemangiomas can be accompanied by other diseases as part of congenital syndromes or metabolopathies that are often genetically inherited. In the present case, it is an autosomal recessive form of SCD syndrome or spondylocostal dysostosis. Conclusion: It is important to consider SCD, i.e., spondylocostal dysostosis, as a rare autosomal recessive disease that can occur as part of hemangiomatosis. Recent studies from 2020 and 2013 have shown the efficacy of topical timolol as well as atenolol which can replace oral propranolol as the first-line agent in the treatment of hemangiomas. In randomized clinical trial (2020), when compared with propranolol, atenolol had similar efficacy and fewer adverse events in the treatment of infants with problematic infantile hemangiomas.
Key words: Infantile Hemangioma, Propranolol; Atenolol, Spondylocostal Dysostosis.
|
